FDA’s Janet Woodcock Set To Retire After 40-Year Career

FDA’s Principal Deputy Commissioner Janet Woodcock, one of the longest-serving and most senior leaders at the agency, is set to retire in early 2024, multiple news sources confirmed Thursday (Nov. 16). Over the course of a four-decade career at the agency, Woodcock has served as acting FDA commissioner, deputy commissioner and director of the Center for Drug Evaluation and Research (CDER), establishing the structure of many of CDER’s current offices, including the Office of Pharmaceutical Quality and the Office of...